Robert Landry

Robert Landry

Director of Finance/CFO at CHECKMATE PHARMACEUTICALS, INC.

Net worth: 867 575 $ as of 29/06/2026

62 year
Health Technology
Consumer Services
Health Services

Profile

Robert E. Landry is Chief Financial Officer & Executive VP-Finance at Regeneron Pharmaceuticals, Inc. He previously was Treasurer & Senior Vice President at Pfizer Inc. Director-Pharmaceutical Marketing & Sales at Wyeth Australia Pty Ltd. Chief Financial Officer of Wyeth New Zealand and Treasurer & Principal Corporate Officer at Wyeth Corp. (which are all subsidiaries of Pfizer Inc.). Mr. Landry received an undergraduate degree from the University of Notre Dame.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
26/05/2026 10,184 ( 0.01% ) 867 575 $ 29/06/2026
11/01/2026 0 ( -.--% ) - $ 29/06/2026

Robert Landry active positions

CompaniesPositionStart
CHECKMATE PHARMACEUTICALS, INC. Director of Finance/CFO 30/05/2022
DECIBEL THERAPEUTICS, INC. Director of Finance/CFO 21/09/2023
CYTOKINETICS, INCORPORATED Director/Board Member 09/02/2025
ZYMEWORKS INC. Director/Board Member 10/08/2025
Director/Board Member -

Former positions of Robert Landry

CompaniesPositionEnd
REGENERON PHARMACEUTICALS, INC. Director of Finance/CFO 04/02/2024
PFIZER INC. Corporate Officer/Principal 30/09/2012
Treasurer 30/09/2009
Wyeth Australia Pty Ltd.
Director of Finance/CFO 31/12/2005
░░░░░ ░░░ ░░░░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Robert Landry's experience

Training of Robert Landry

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

76

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Wyeth Australia Pty Ltd.

Wyeth New Zealand

Health Technology

Health Technology

Health Services

Health Technology